.png)
German (DE) 
English (US) 
Spanish (ES) 
French (FR) 
Hindi (IN) 
Italian (IT) 
Russian (RU) IDEXX Laboratories (IDXX) Price Target Hiked to $580 at Leerink Partners
Ascendis Pharma (ASND) Rated as a Hold at Cannacord Genuity on Growth Hormone Prospects
Gilead (GILD) Downplays FDA Decision to Pause HIV Combination Trial over Safety Concern
Cigna (CI) Unveils AI-Powered Tools to Enhance Healthcare Delivery
Your briefing
Popular News
Why Redwire Stock Is Down Big Today
1 week ago
